Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LAB NASDAQ:PRE NASDAQ:SENS NYSE:TT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABStandard BioTools$1.03$0.95$0.87▼$1.72$402.08M1.322.05 million shs1.15 million shsPREPrenetics Global$16.77$18.41$5.58▼$23.63$282.98M0.15233,247 shs192,163 shsSENSSenseonics Holdings, Inc. Common Stock$6.34$6.37$4.79▼$12.58$265.03M1.051.35 million shs601,141 shsTTTrane Technologies$451.57+0.1%$452.86$348.06▼$503.47$99.70B1.251.38 million shs1.19 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABStandard BioTools0.00%+4.59%+14.51%-7.21%+11.76%PREPrenetics Global0.00%+7.43%-8.51%+7.43%+62.66%SENSSenseonics Holdings, Inc. Common Stock0.00%+9.88%-10.07%-22.59%+633,999,900.00%TTTrane Technologies0.00%-3.23%-7.25%-1.74%+6.57%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABStandard BioTools$1.03$0.95$0.87▼$1.72$402.08M1.322.05 million shs1.15 million shsPREPrenetics Global$16.77$18.41$5.58▼$23.63$282.98M0.15233,247 shs192,163 shsSENSSenseonics Holdings, Inc. Common Stock$6.34$6.37$4.79▼$12.58$265.03M1.051.35 million shs601,141 shsTTTrane Technologies$451.57+0.1%$452.86$348.06▼$503.47$99.70B1.251.38 million shs1.19 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABStandard BioTools0.00%+4.59%+14.51%-7.21%+11.76%PREPrenetics Global0.00%+7.43%-8.51%+7.43%+62.66%SENSSenseonics Holdings, Inc. Common Stock0.00%+9.88%-10.07%-22.59%+633,999,900.00%TTTrane Technologies0.00%-3.23%-7.25%-1.74%+6.57%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABStandard BioTools 1.67Reduce$1.3531.07% UpsidePREPrenetics Global 2.50Moderate Buy$32.3392.80% UpsideSENSSenseonics Holdings, Inc. Common Stock 2.67Moderate Buy$17.00168.14% UpsideTTTrane Technologies 2.61Moderate Buy$506.5612.18% UpsideCurrent Analyst Ratings BreakdownLatest PRE, LAB, SENS, and TT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2026TTTrane Technologies JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$460.00 ➝ $476.005/12/2026SENSSenseonics Holdings, Inc. Common Stock HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$18.50 ➝ $14.005/11/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Sell (D+)5/11/2026SENSSenseonics Holdings, Inc. Common Stock Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$9.00 ➝ $8.005/1/2026TTTrane Technologies CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$525.00 ➝ $570.005/1/2026TTTrane Technologies Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$440.00 ➝ $501.005/1/2026TTTrane Technologies BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$507.00 ➝ $585.005/1/2026TTTrane Technologies KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$525.00 ➝ $555.004/24/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026PREPrenetics Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026TTTrane Technologies KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$500.00 ➝ $525.00(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABStandard BioTools$85.33M4.71N/AN/A$1.44 per share0.72PREPrenetics Global$92.39M3.06N/AN/A$9.27 per share1.81SENSSenseonics Holdings, Inc. Common Stock$35.26M7.52N/AN/A$0.82 per share7.73TTTrane Technologies$21.32B4.68$14.98 per share30.14$38.96 per share11.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABStandard BioTools-$74.90M$0.205.15N/AN/A73.46%-8.18%-6.43%8/10/2026 (Estimated)PREPrenetics Global-$37.71M-$4.02N/AN/AN/A-61.33%-19.61%-15.33%N/ASENSSenseonics Holdings, Inc. Common Stock-$69.11M-$2.00N/AN/AN/A-213.87%-129.97%-67.14%N/ATTTrane Technologies$2.92B$12.9334.9226.822.0713.41%35.55%13.73%7/29/2026 (Estimated)Latest PRE, LAB, SENS, and TT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026SENSSenseonics Holdings, Inc. Common Stock-$0.65-$0.71-$0.06-$0.71N/A$11.71 million4/30/2026Q1 2026TTTrane Technologies$2.53$2.63+$0.10$2.62$4.81 billion$4.97 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthLABStandard BioToolsN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ASENSSenseonics Holdings, Inc. Common StockN/AN/AN/AN/AN/ATTTrane Technologies$4.200.93%-34.81%32.48%5 YearsLatest PRE, LAB, SENS, and TT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/1/2026TTTrane Technologiesquarterly$1.050.98%6/5/20266/5/20266/30/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLABStandard BioToolsN/A12.3611.92PREPrenetics GlobalN/A2.972.72SENSSenseonics Holdings, Inc. Common Stock1.053.513.19TTTrane Technologies0.461.100.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABStandard BioTools53.74%PREPrenetics Global25.01%SENSSenseonics Holdings, Inc. Common Stock12.36%TTTrane Technologies82.97%Insider OwnershipCompanyInsider OwnershipLABStandard BioTools23.16%PREPrenetics Global7.80%SENSSenseonics Holdings, Inc. Common Stock4.70%TTTrane Technologies0.14%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABStandard BioTools620390.37 million299.96 millionOptionablePREPrenetics Global116.87 million15.56 millionNot OptionableSENSSenseonics Holdings, Inc. Common Stock9041.80 million39.84 millionN/ATTTrane Technologies44,000221.05 million220.75 millionOptionablePRE, LAB, SENS, and TT HeadlinesRecent News About These CompaniesWhy Trane Technologies (TT) is a top growth stock for the long term4 hours ago | msn.comWhy Trane Technologies (TT) is a Top Growth Stock for the Long-TermMay 25 at 10:46 AM | zacks.comMain Street Research LLC Has $369,000 Stock Position in Trane Technologies plc $TTMay 25 at 6:34 AM | marketbeat.comTrane Technologies plc $TT Shares Sold by Fisher Asset Management LLCMay 25 at 4:34 AM | marketbeat.comShelter Rock Management LLC Acquires Shares of 12,929 Trane Technologies plc $TTMay 24 at 6:09 AM | marketbeat.comTrane Technologies plc $TT Shares Acquired by Global Retirement Partners LLCMay 24 at 5:14 AM | marketbeat.comIs Wall Street bullish or bearish on Trane Technologies stock?May 22 at 11:31 PM | msn.comA Look At Trane Technologies (TT) Valuation After Recent Share Price CoolingMay 22 at 11:31 PM | finance.yahoo.comIs Trane Technologies (TT) The Best Under-The-Radar AI Stock?May 22 at 11:31 PM | finance.yahoo.comVan Hulzen Asset Management LLC Takes $7.67 Million Position in Trane Technologies plc $TTMay 22 at 7:46 AM | marketbeat.comLeonteq Securities AG Takes Position in Trane Technologies plc $TTMay 22 at 5:54 AM | marketbeat.comRathbones Group PLC Boosts Stock Holdings in Trane Technologies plc $TTMay 22 at 5:45 AM | marketbeat.comTrane Technologies plc $TT Shares Purchased by HighTower Advisors LLCMay 22 at 5:09 AM | marketbeat.comPNC Financial Services Group Inc. Sells 4,500 Shares of Trane Technologies plc $TTMay 21, 2026 | marketbeat.comProShare Advisors LLC Acquires 3,574 Shares of Trane Technologies plc $TTMay 21, 2026 | marketbeat.comTrane Technologies plc (TT) Presents at Wolfe Research 19th Annual Global Transportation & Industrials Conference TranscriptMay 20, 2026 | seekingalpha.comTrane Technologies plc (TT) Presents at Wolfe Research 19th Annual Global Transportation & Industrials Conference - SlideshowMay 20, 2026 | seekingalpha.comTrane Technologies Opens Global AI Lab and Showroom, Accelerating the Future of Autonomous BuildingsMay 20, 2026 | businesswire.comTrane Technologies plc $TT Shares Bought by Saranac Partners LtdMay 20, 2026 | marketbeat.comTrane Technologies plc $TT Position Trimmed by Resona Asset Management Co. Ltd.May 20, 2026 | marketbeat.comTrane Technologies plc $TT Shares Sold by TD Private Client Wealth LLCMay 20, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesRoblox Stock Slides to New Low as Safety Changes Weigh on OutlookBy Jennifer Ryan Woods | May 3, 2026The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000By Jeffrey Neal Johnson | May 12, 2026The Crude Reality: Pullback Creates High-Conviction Opportunity in ChevronBy Jeffrey Neal Johnson | April 29, 2026Shopify’s Valuation Crisis Creates Opportunity in 2026By Thomas Hughes | May 5, 20263 Stocks to Own If Gas Prices Keep RisingBy Dan Schmidt | May 16, 2026PRE, LAB, SENS, and TT Company DescriptionsStandard BioTools NASDAQ:LAB$1.03 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.03 0.00 (0.00%) As of 05/22/2026 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Prenetics Global NASDAQ:PRE$16.77 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$17.19 +0.42 (+2.50%) As of 05/22/2026 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Senseonics Holdings, Inc. Common Stock NASDAQ:SENS$6.34 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$6.21 -0.13 (-2.05%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Trane Technologies NYSE:TT$451.57 +0.55 (+0.12%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$451.51 -0.06 (-0.01%) As of 05/22/2026 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Trane Technologies plc, together with its subsidiaries, designs, manufactures, sells, and services of solutions for heating, ventilation, air conditioning, custom, and custom and transport refrigeration in Ireland and internationally. It offers air conditioners, exchangers, and handlers; airside and terminal devices; air sourced heat pumps, auxiliary power units; chillers; coils and condensers; gensets; dehumidifiers; ductless; furnaces; home automation products; humidifiers; indoor air quality assessments and related products; large and light commercial unitary products; refrigerant reclamation products; thermostats/controls; transport heater products; variable refrigerant flow products; and water source heat pumps. The company also provides building management, telematic, control, energy efficiency and infrastructure program, geothermal, thermal energy, thermostats, rate chambers, package heating and cooling, temporary heating and cooling, and unitary systems; bus, rail, and multi-pipe heating, ventilation, and air conditioning systems; and container, diesel-powered, truck, industrial, rail, self-powered truck, trailer, and vehicle-powered truck refrigeration and air filtration systems, as well as aftermarket and OEM parts and supplies. In addition, it offers energy and facility management, installation and performance contracting, repair and maintenance, and rental services. It markets and sells its products under the Trane and Thermo King brands through sales offices, distributors, and dealers; and through sales and service companies with a supporting chain of distributors. The company was formerly known as Ingersoll-Rand Plc and changed its name to Trane Technologies plc in March 2020. Trane Technologies plc was founded in 1885 and is headquartered in Swords, Ireland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Ross Stores Earnings Beat Sends Stock To New Highs Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins Apparel Earnings Winners and Losers: Ralph Lauren Takes Off SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
